| Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma JM Przystal, S Waramit, MZI Pranjol, W Yan, G Chu, A Chongchai, ... EMBO Molecular Medicine 11 (4), e8492, 2019 | 80 | 2019 |
| Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models NA Vitanza, MC Biery, C Myers, E Ferguson, Y Zheng, EJ Girard, ... Neuro-oncology 23 (3), 376-386, 2021 | 64 | 2021 |
| Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas JM Przystal, C Cianciolo Cosentino, S Yadavilli, J Zhang, S Laternser, ... Neuro-oncology 24 (9), 1438-1451, 2022 | 60 | 2022 |
| Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp78 Promoter Induces Tumor Regression A Kia, JM Przystal, N Nianiaris, ND Mazarakis, PJ Mintz, A Hajitou Molecular cancer therapeutics 11 (12), 2566-2577, 2012 | 51 | 2012 |
| Targeting CSF1R alone or in combination with PD1 in experimental glioma JM Przystal, H Becker, D Canjuga, F Tsiami, N Anderle, AL Keller, A Pohl, ... Cancers 13 (10), 2400, 2021 | 49 | 2021 |
| Efficacy of arginine depletion by ADI-PEG20 in an intracranial model of GBM JM Przystal, N Hajji, C Khozoie, A Renziehausen, Q Zeng, F Abaitua, ... Cell death & disease 9 (12), 1192, 2018 | 45 | 2018 |
| Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer K Suwan, T Yata, S Waramit, JM Przystal, CA Stoneham, K Bentayebi, ... Proceedings of the National Academy of Sciences 116 (37), 18571-18577, 2019 | 43 | 2019 |
| Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage JM Przystal, E Umukoro, CA Stoneham, T Yata, K O’Neill, N Syed, ... Molecular oncology 7 (1), 55-66, 2013 | 38 | 2013 |
| Doxorubicin improves cancer cell targeting by filamentous phage gene delivery vectors E Tsafa, K Bentayebi, S Topanurak, T Yata, J Przystal, D Fongmoon, ... International Journal of Molecular Sciences 21 (21), 7867, 2020 | 19 | 2020 |
| The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction E Tsafa, M Al-Bahrani, K Bentayebi, J Przystal, K Suwan, A Hajitou Oncotarget 7 (32), 52135, 2016 | 15 | 2016 |
| Argyrin F treatment‐induced vulnerabilities lead to a novel combination therapy in experimental glioma B Walter, D Canjuga, SG Yüz, M Ghosh, P Bozko, JM Przystal, ... Advanced Therapeutics 4 (9), 2100078, 2021 | 10 | 2021 |
| Multiparametric longitudinal profiling of RCAS-tva-Induced PDGFB-driven experimental glioma H Becker, S Castaneda-Vega, K Patzwaldt, JM Przystal, B Walter, ... Brain Sciences 12 (11), 1426, 2022 | 9 | 2022 |
| Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging V Vassileva, M Braga, C Barnes, J Przystal, A Ashek, L Allott, D Brickute, ... Biomedicines 9 (7), 811, 2021 | 8 | 2021 |
| Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition MS Koch, S Czemmel, F Lennartz, S Beyeler, S Rajaraman, JM Przystal, ... Neuro-oncology advances 2 (1), vdaa115, 2020 | 6 | 2020 |
| Efficacy of convection enhanced delivery of MTX110 (soluble panobinostat) in preclinical Diffuse Intrinsic Pontine Glioma models using metabolic hyperpolarized 13C imaging JM Przystal, I Park, J Zhang, P Hadaczek, K Bankiewicz, N Gupta, ... EJC Paediatric Oncology 2, 100021, 2023 | 4 | 2023 |
| HGG-32. ONC201 AND ONC206 TARGET TUMOR CELL METABOLISM IN PEDIATRIC DIFFUSE MIDLINE GLIOMA PRECLINICAL MODELS JM Przystal, CC Cosentino, S Yadavilli, J Zhang, S Laternser, ER Bonner, ... Neuro-Oncology 23 (Supplement_1), i23-i24, 2021 | 3 | 2021 |
| DIPG-64. International preclinical drug discovery and biomarker program informing an adoptive combinatorial trial for diffuse midline gliomas JM Przystal*, S Yadavilli*, CC Abadi*, VN Yadav, S Laternser, ... Neuro-oncology 22 (Supplement_3), iii300-iii300, 2020 | 2 | 2020 |
| 672. Hybrid AAV/Phage Vector Enhances Chemotherapy Efficacy Against Cancer K Suwan, E Tsafa, J Przystal, P Asavarut, A Hajitou Molecular Therapy 24, S265-S266, 2016 | 1 | 2016 |
| Abstracts from the 2012 BNOS Conference S Bell, E Murray, R Muirhead, A James, Z Hanzely, R Jackson, W Stewart, ... Neuro-oncology 14 (Suppl 2), ii1-ii12, 2012 | 1 | 2012 |
| DIPG-38. VAL-083 IN COMBINATION WITH AZD1775 FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA B Subramaniam, D Roy, A Woldegerima, J Przystal, J Zhang, S Laternser, ... Neuro-Oncology 26 (Suppl 4), 0, 2024 | | 2024 |
